Wave Life Sciences WVE
NASDAQ WVE
$4.84 +0.14 (+2.87%)
As of: Sep 4, 2026 · 2:36 PM EDT

Wave Life Sciences (WVE) Profit After Tax (2014 - 2026)

Wave Life Sciences' (WVE) quarterly Profit After Tax came in at -$69.4 million in Q2 2026, down 37.42% YoY from -$110.8 million in Q2 2025, and down 165.86% on a QoQ basis from -$26.1 million in Q1 2026.

Analysis

Wave Life Sciences (WVE) Profit After Tax (2014 - 2026) Analysis & Trends

Wave Life Sciences (WVE) has 13 years of Profit After Tax data on file, last reported at -$69.4 million in Q2 2026.

  • Quarterly Profit After Tax fell 37.42% year-over-year to -$69.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$202.5 million (down 55.8% YoY) and the FY2025 annual result came in at -$204.4 million, down 110.38% from the prior year.
  • Profit After Tax eased to -$69.4 million in Q2 2026, from -$26.1 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $29.2 million in Q4 2024 to a low of -$69.4 million in Q2 2026.
  • A 5-year average of -$34.2 million and a median of -$38.4 million in 2022 frame the typical range for Profit After Tax.
  • The widest YoY moves for Profit After Tax: up 279.96% in 2024, down 951.9% in 2024.
  • Tracing WVE's Profit After Tax over 5 years: stood at -$43.6 million in 2022, then soared by 62.86% to -$16.2 million in 2023, then surged by 279.96% to $29.2 million in 2024, then tumbled by 282.43% to -$53.2 million in 2025, then plunged by 30.42% to -$69.4 million in 2026.
  • The last three Profit After Tax figures came in at -$69.4 million (Q2 2026), -$26.1 million (Q1 2026), and -$53.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -644.37 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 81.49 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -16.62 Mn
10 Wave Life Sciences 987.40 Mn 619.39 Mn - -69.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -69.36 Mn
Mar 31, 2026 -26.09 Mn
Dec 31, 2025 -53.18 Mn
Sep 30, 2025 -53.88 Mn
Jun 30, 2025 -50.47 Mn
Mar 31, 2025 -46.88 Mn
Dec 31, 2024 29.15 Mn
Sep 30, 2024 -61.78 Mn
Jun 30, 2024 -32.92 Mn
Mar 31, 2024 -31.56 Mn
Dec 31, 2023 -16.20 Mn
Sep 30, 2023 7.25 Mn
Jun 30, 2023 -21.10 Mn
Mar 31, 2023 -27.41 Mn
Dec 31, 2022 -43.62 Mn
Sep 30, 2022 -39.08 Mn
Jun 30, 2022 -41.30 Mn
Mar 31, 2022 -37.81 Mn
Dec 31, 2021 -34.86 Mn
Sep 30, 2021 -6.24 Mn